Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01468675 · ClinicalTrials.gov registry record · NA
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 6,075
- Enrollment target
NCT01468675: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT01468675 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 6,075 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (333% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01468675, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,075 participants
- Enrollment target
Study Summary
We evaluated whether collection of risk factors to generate an electronic health record (EHR)-linked personalized health risk appraisal (HRA) for coronary heart disease (CHD), diabetes, breast and colorectal cancer (CRC) was associated with improved patient-provider communication, risk assessment, and breast cancer screening plans in the next year.
Interventions
- OTHER Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,075 participants |
| Start Date | 2013-02 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT01468675 record still lists
NCT01468675 is an interventional study that assigns participants to a tested intervention. Its 6,075 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (333% higher).
The record links to 0 conditions, and to 1 intervention - of which Intervention is the first listed.
NCT01468675 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01468675 about?
NCT01468675 is a clinical study titled "Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care". We evaluated whether collection of risk factors to generate an electronic health record (EHR)-linked personalized health risk appraisal (HRA) for coronary heart disease (CHD), diabetes, breast and colorectal cancer (CRC) was associated with improved patient-provider communication, risk assessment, a...
What is the current status of trial NCT01468675?
This trial is currently completed. It is a NA study. The enrollment target is 6,075 participants. The study started on 2013-02. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01468675?
The interventions under investigation include: Intervention (OTHER).
Who is sponsoring clinical trial NCT01468675?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01468675's enrollment target sits among peer trials
6,075 22nd of 2000 higher than 1,979 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07166861 · 6,080 participants · NA
Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
- NCT05884190 · 6,030 participants · NA
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
- NCT04774159 · 6,150 participants · Phase 3
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- NCT06304168 · 6,150 participants
Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia